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The cellular location of the so-called ‘thymic hormone’ prothymosin a has been studied by microinjection into the cyto- 
plasm of Xenopus oocytes, followed by separate monitoring of nuclear and cytoplasmic oncentrations. It is shown that 
prothymosin a migrates to the nucleus at a rate comparable to that of histone Hl. Prothymosin a cannot therefore be 
a hormone in the usual sense of the word. 
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1. INTRODUCTION 
A peptide of 28 residues, named thymosin al, 
originally isolated from calf thymus [l] has been 
reported to have immuno-restorative properties 
and to offer protection against opportunistic infec- 
tions [2]. It is frequently referred to as a ‘thymic 
hormone’ since significant levels have been 
reported in serum [3]. For a review see Low and 
Goldstein [4]. More careful extraction of calf 
thymus leads to the isolation of a longer peptide of 
110 amino acids, prothymosin (Y, but little 
thymosin cyl [5]. Prothymosin a includes thymosin 
LYI as its 28 N-terminal amino acids. Since pro- 
thymosin LY is reported to protect mice against op- 
portunistic infection at much lower doses than 
thymosin w [6], the latter is probably a proteolytic 
product of prothymosin LY, derived largely from 
the extraction procedures used. The amino acid se- 
quences of the rat, human and bovine prothymosin 
LY proteins have been determined [7-91. They are 
all very closely related and contain -50% acidic 
residues, of which 24 are in a central section, 
broken only by interspersed glycine residues. In 
bovine prothymosin (Y there are only 7 large 
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hydrophobic and no aromatic residues, suggesting 
that prothymosin a is not a folding protein. 
A hormonal function for prothymosin a has 
been thrown into doubt, firstly by the demonstra- 
tion, using cDNA cloning, that there is no signal 
peptide in the primary translation product [lO,ll], 
and also from the observation of a broad tissue 
distribution for the protein [ 121. An intracellular 
function for prothymosin CY, related to cell growth, 
is suggested by the observation that its mRNA level 
rises sharply in stimulated lymphocyte cultures 
[lo]. That this function might even be nuclear was 
proposed on the basis of a putative nuclear 
localisation sequence near the C-terminus of pro- 
thymosin CY [13]. 
In the experiments reported here, radio- 
iodinated prothymosin CY was used for cytoplasmic 
injection of Xenopus Levis oocytes to demonstrate 
that the protein indeed migrates to the nucleus. 
2. MATERIALS AND METHODS 
Prothymosin (Y was purified from whole calf thymus cells by 
extraction with 5% perchloric acid followed by purification by 
ion-exchange chromatography on Sephadex CM-25, size frac- 
tionation on Sephadex G75 and finally by a further round of 
ion-exchange chromatography on Sephadex SPC-25 (Watts et 
al., in preparation). 
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reagent (spec. act. 2000 Ci/mmol, Amersham) was dried under 
a stream of dry nitrogen and resuspended in 1 81 dimethylfor- 
mamide (DMF). 1 nmol of protein (i.e. 12 pg prothymosin (Y, 
20/g histone Hl and 66 gg BSA) was dissolved in 19 81 of 
100 mM sodium borate, pH 8.5, 50 mM NaCl and added to the 
DMF. Each sample was reacted on ice for 45 min, and the 
labelled protein separated from free radioactivity on a small 
column of Sephadex (325, previously flushed with 0.25% 
gelatin in running buffer (0.5% formic acid). Each sample was 
lyophilised, resuspended, counted and then diluted with 
unlabelled protein to give the required protein concentration 
and specific activity in 88 mM NaCl, 10 mM Tris, pH 7.5 (in- 
jection buffer). 
A mature female X. luevis was killed and an ovary removed. 
Stage V-VI oocytes were separated from the membrane and 
maintained in modified Barth’s saline at 18-19”C, as described 
[15]. Individual oocytes were injected into the vegetal 
hemisphere with 50 nl of the appropriate sample, 
0.4 pmol/oocyte, and incubated in saline for varying lengths of 
time at 18°C. Ten oocytes were injected per time point. After 
fixing in 20% trichloroacetic acid (TCA) for 15 min at 18”C, 
the nuclei were removed using two pairs of watchmaker’s 
forceps [16]. For the zero time point, oocytes were transferred 
to 20% TCA immediately after injection. Pooled nuclei and 
cytoplasms were counted using a Minaxi 5000 Auto-Gamma 
counter, resuspended in 50~1 of 10 M urea and insoluble 
material spun to the bottom of the tube. Aliquots were counted, 
diluted with 2 x SDS gel loading buffer, analysed by SDS gel 
electrophoresis [17], visualised with Coomassie and then dried 
down and subjected to autoradiography using pre-flashed film 
[18]. Densitometry of autoradiographs was performed on a 
Vitatron and peak areas obtained by weighing. 
3. RESULTS 
Xenopus oocytes were injected with iodinated 
prothymosin a, with histone Hl as a positive con- 
trol [16,19] and with BSA as a non-migrating 
negative control. 10 oocytes were injected per pro- 
tein for each time point, using 0.4 pmol of all 3 
proteins per oocyte (5 ng in the case of pro- 
thymosin (Y). After incubation, oocytes were 
harvested by transfer to a 20% TCA solution. 
Following manual enucleation, pooled nuclei and 
cytoplasms were separately gamma counted and 
proteins were extracted by suspension in SDS gel 
loading buffer. Aliquots of the extracts were again 
gamma counted to correct for any differential pro- 
tein extraction between nuclei and cytoplasms. 
Samples were loaded onto 15% polyacrylamide, 
0.1% SDS gels, which were subsequently visualised 
by autoradiography against standard labelled pro- 
thymosin cy. 
One approach to analysis of the results is to 
follow the time course of radiolabel transfer to the 
nucleus by plotting the ratio of nuclear to 
18 
cytoplasmic counts per oocyte. In order to reflect 
relative protein concentrations, the counts ratio 
was multiplied by 88/12, which represents the 
relative accessible volumes of cytoplasm to nucleus 
[ 161. Fig. 1 shows the results for an experiment hat 
continued up to 48 h for prothymosin cy. It appears 
that whereas BSA remains entirely in the 
cytoplasm, prothymosin a steadily accumulates in 
the nucleus. Despite some experimental variation, 
histone Hl is also seen to migrate to the nucleus. 
A possible problem in following counts as a 
measure of migration is that any degradation of 
protein is not observed. Cytoplasmic degradation 
and loss of radiolabelled peptides from the oocytes 
would increase the apparent nuclear to cytoplasmic 
ratio. This does not appear to be a major problem 
since the prothymosin LY counts per whole oocyte 
typically drop only by about 50% over 24 h. 
Nevertheless there is an advantage to monitoring 
intact protein on polyacrylamide gels. Fig.2 shows 
a 24 h time course of prothymosin (Y migration. 
Densitometry of the autoradiograph yields the 
relative amounts of nuclear and cytoplasmic pro- 
tein, when corrected for the number of nuclei/ 
n BSA 
0 10 20 30 40 50 
Time (hrs) 
Fig.1. Time course of the relative nuclear to cytoplasmic 
concentration ratio of prothymosin (Y label. Histone Hl and 
BSA label are included for comparison. 
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Fig.2. Autoradiograph of an SDS gel showing the time course 
of migration of prothymosin LY from cytoplasm (C) to nucleus 
(N). The concentration ratio [N]/[C] was calculated from 
densitometry and taking into account the relative accessible 
volumes of cytoplasm and nucleus (88/12). 
cytoplasms loaded per lane. The concentration 
ratio of intact prothymosin (Y was again obtained 
using the nuclear/cytoplasmic volume ratio of 
12/88. The results are included in fig.2. Although 
the nuclear/cytoplasmic ratio for prothymosin LY 
increases between 12 and 24 h, this is due to a 
decrease in the intensity of the cytoplasmic band 
rather than an increase in the nuclear band, which 
reaches a maximum by 12 h. There is therefore 
significant cytoplasmic degradation between 12 
and 24 h and we conclude that migration is essen- 
tially complete within 12 h. Experiments continued 
up to 48 h show that the prothymosin LY remains 
stable in the nucleus for this period (not shown). 
An interesting feature of fig.2 concerns the 
radiolabelled minor components in the pro- 
thymosin LY sample, which clearly react more readi- 
ly with the Bolton and Hunter reagent than 
prothymosin cy since they are not apparent in a 
Coomassie stained gel of the prothymosin cy used 
for injection. Over the period in which the pro- 
thymosin LY band appears in the nuclear lane, there 
is no sign of the impurity proteins. Even at 24 h 
they are still apparent in the cytoplasm. This in- 
dicates the specific nature of the prothymosin (Y 
migration. 
4. DISCUSSION 
A nuclear function for prothymosin (Y in 
transcription is suggested by its highly acidic 
nature and similarity to a number of other nuclear 
proteins. Proteins HMG14 and 17 both have acidic 
stretches, particularly towards their C-terminus, 
but this is not in the form of long contiguous stret- 
ches of acidic residues, as in prothymosin (Y. 
Nevertheless, HMG14 and 17 are of similar size to 
prothymosin cy and are likewise non-folding pro- 
teins [22,23] and differ only in having a higher pro- 
portion of basic residues. Proteins HMGl and 2, 
in contrast, each have a long contiguous acidic 
stretch at their C-terminus but differ from pro- 
thymosin a in having normally folded N-terminal 
domains [24,25]. HMG14 and 17 have been shown 
to be present on the nucleosomes of actively 
transcribed chromatin [26], whilst HMGl and 2 
are thought to bind to the linker DNA between 
nucleosomes [27] and may also serve to promote 
transcription [28,29]. The major nucleolar protein, 
nucleolin, also has several uninterrupted acidic 
stretches [30], the longest of which is 33 residues, 
not unlike the 30-residue long acidic tail of HMGl 
[31]. Nucleolin has been postulated to play a role 
in both pre rRNA transcription and pre-ribosome 
assembly [32]. 
Although a heterologous ystem is used here, in- The activating domains of the yeast transcrip- 
jecting a bovine protein into Xenopus oocytes, the tion factors GAL4 and GCN4 are also strongly 
effectiveness of sequences in large T-antigen for 
stimulating migration in Xenopus oocytes has been 
demonstrated [20]. Bovine prothymosin cy contains 
the sequence Asp-Thr-Lys-Lys-Gln-Lys-Thr-Asp, 
which includes a tetrapeptide similar to that in 
large T-antigen, Lys-Lys-Arg-Lys, defined as 
responsible for its nuclear migration [21]. Se- 
quences similar or identical to the prothymosin (Y 
tetrapeptide are found in other nuclear proteins. 
For example, nucleolin contains the sequence 
Glu-Ala-Lvs-Lvs-Gln-Lvs-Val-Glu which is iden- 
tical to bovine prothymosin (Y within the tetrapep- 
tide and likewise contains acidic residues located 
two amino acids away on either side. Although the 
present experiments do not show that this sequence 
is indeed that responsible for nuclear migration, 
they do lend support to the hypothesis of Gomez- 
Marquez and Segade [13] that this region of the 
protein can effect nuclear migration. Our result in- 
dicates that prothymosin LY cannot be a hormone in 
the conventional sense of a secreted ‘messenger’ 
molecule. 
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acidic, though they do not contain the contiguous 
sequences characteristic of HMG1/2 and pro- 
thymosin LY [33,34]. These domains probably do 
not form defined tertiary structures. 
An alternative functional role suggested by the 
highly acidic stretch in prothymosin LY is one akin 
to that of Xenopus nucleoplasmin and nuclear pro- 
tein Nl [35,36], i.e. as an assembly factor. Both of 
these Xenopus proteins include very acidic stret- 
ches but also contain folding regions, unlike pro- 
thymosin a. 
Although nothing is known of the nuclear func- 
tion of prothymosin (Y, a role in active 
chromosomal functions such as transcription or 
replication, is consistent with two observations: (i) 
the sharp rise in its mRNA on stimulation of quies- 
cent cells, [lo], and (ii) its virtual absence from 
non-dividing cells, e.g. brain, and its high level in 
tissues containing proliferative cells, such as 
thymus and spleen [12]. 
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